Nxt2b Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 2
Professionals
  • Investments
  • 33
  • Portfolio
  • 10
  • Exits
  • 20
Exits

Nxt2b General Information

Description

Nxt2b is a venture capital firm that focuses on growth equity investments in healthcare, medical devices, technology, consumer and specialty pharmaceutical companies. The firm is based in Uppsala, Sweden and was founded in 2011.

Contact Information

Website
www.nxt2b.com
Year Founded
2011
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Daghammarskjölds väg 40 C
  • 751 83 Uppsala
  • Sweden
+46 018-50 00 00

Nxt2b Investments (33)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Bioimics 01-Jan-2018 Later Stage VC Drug Discovery Generating Revenue 00000 000000000 00000000
000000000 13-Nov-2013 00000 00000 00000 Biotechnology Generating Revenue 00000 000000000 00000000
00000-0 02-Sep-2013 00000 00000 00.000 Diagnostic Equipment Out of Business 00000 000000000 00000000
000000 000000000 28-Jan-2013 000000000 00 Other Devices and Supplies Generating Revenue 00000 000000000 00000000
000000 00000000000 03-Dec-2012 0000 00.000 Pharmaceuticals Generating Revenue/Not Profitable
00000 000000000 25-Jan-2012 0000 00.000 Biotechnology Generating Revenue/Not Profitable 00000 000000000 00000000
00000000 000000000 06-Dec-2011 00 000000000 00.00 Pharmaceuticals Generating Revenue 00000 000000000 00000000
000000 00000000000 25-Oct-2011 0000 00.000 Pharmaceuticals Generating Revenue/Not Profitable
Vivolux 22-Sep-2011 Buyout/LBO Drug Discovery Generating Revenue/Not Profitable 00000000 000000
Olink Proteomics 30-Aug-2011 Early Stage VC Discovery Tools (Healthcare) Generating Revenue/Not Profitable 00000 000000000 00000000
You’re viewing 10 of 33 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nxt2b Exits (20)

Company Name Exit Date Exit Type Exit Size
Capilet Genetics 29-Mar-2021 Out of Business
00000 0000000000 12-Mar-2019 0000000000
00000-0 01-May-2018 000 00 00000000
0000000 0000000000 31-Mar-2017 000000000000000000
00000000 01-Feb-2016 000 00 00000000
000000 0000000 01-Jan-2016 000000000000
000000 01-Aug-2013 000 00 00000000
000000 01-Apr-2012 000 00 00000000
Bencar Out of Business
BioLamina Secondary Transaction - Private
You’re viewing 10 of 20 exits. Get the full list »

Nxt2b Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Nxt2b Team (9)

Name Title Deals Funds Boards Office
Erika Kjellberg Eriksson Chief Executive Officer & Chairman 00 00 Uppsala, Sweden
Jaana Jansson Financial Manager Uppsala, Sweden
Kristin Ermanbriks Project Co-ordinator Uppsala, Sweden
You’re viewing 3 of 9 team members. Get the full list »